A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease

NCT00216502 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Dementia
Mental Disorders
Brain Diseases

Interventions

DRUG: galantamine hydrobromide

Sponsor

Janssen-Cilag S.p.A.